NVTAQ — InVitae Share News
0.000.00%
Last trade - 00:00- $0.11m
- $1.10bn
- $516.30m
Labcorp rises after beating Q2 profit and revenue estimates
Deals of the day-Mergers and acquisitions
Labcorp beats quarterly estimates on strong testing demand
Deals of the day-Mergers and acquisitions
Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln
Law firm Kirkland conflicted in Invitae bankruptcy, DOJ watchdog says
Invitae gets court approval for five-month bankruptcy sale
Genetic test maker Invitae files for bankruptcy protection in US (updated)
Genetic test maker Invitae files for voluntary Chapter 11 protection